BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17604335)

  • 1. Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1alpha,25-dihydroxyvitamin D(3) in prostate cancer cells.
    Xu Y; Fang F; St Clair DK; Josson S; Sompol P; Spasojevic I; St Clair WH
    Mol Cancer Ther; 2007 Jul; 6(7):2048-56. PubMed ID: 17604335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RelB-dependent differential radiosensitization effect of STI571 on prostate cancer cells.
    Xu Y; Fang F; Sun Y; St Clair DK; St Clair WH
    Mol Cancer Ther; 2010 Apr; 9(4):803-12. PubMed ID: 20371728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HZ08 suppresses RelB-activated MnSOD expression and enhances Radiosensitivity of prostate Cancer cells.
    Zhang Y; Xu Z; Ding J; Tan C; Hu W; Li Y; Huang W; Xu Y
    J Exp Clin Cancer Res; 2018 Jul; 37(1):174. PubMed ID: 30053873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RelB Expression Determines the Differential Effects of Ascorbic Acid in Normal and Cancer Cells.
    Wei X; Xu Y; Xu FF; Chaiswing L; Schnell D; Noel T; Wang C; Chen J; St Clair DK; St Clair WH
    Cancer Res; 2017 Mar; 77(6):1345-1356. PubMed ID: 28108513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SN52, a novel nuclear factor-kappaB inhibitor, blocks nuclear import of RelB:p52 dimer and sensitizes prostate cancer cells to ionizing radiation.
    Xu Y; Fang F; St Clair DK; Sompol P; Josson S; St Clair WH
    Mol Cancer Ther; 2008 Aug; 7(8):2367-76. PubMed ID: 18723484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells.
    Josson S; Xu Y; Fang F; Dhar SK; St Clair DK; St Clair WH
    Oncogene; 2006 Mar; 25(10):1554-9. PubMed ID: 16261162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells.
    Holley AK; Xu Y; St Clair DK; St Clair WH
    Ann N Y Acad Sci; 2010 Jul; 1201():129-36. PubMed ID: 20649549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockage of RelB expression by gene silencing enhances the radiosensitivity of androgen‑independent prostate cancer cells.
    Zhu HC; Qiu T; Dan C; Liu XH; Hu CH
    Mol Med Rep; 2015 Feb; 11(2):1167-73. PubMed ID: 25370388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RelB-BLNK Axis Determines Cellular Response to a Novel Redox-Active Agent Betamethasone during Radiation Therapy in Prostate Cancer.
    Chaiswing L; Xu F; Zhao Y; Thorson J; Wang C; He D; Lu J; Ellingson SR; Zhong W; Meyer K; Luo W; St Clair W; Clair DS
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [RNA interference of RelB enhances the radiosensitivity of prostate cancer cell line RM-1 in mice].
    Zhu B; Yang LY; Zhao XK; Jiang HY; Zhu L
    Zhonghua Nan Ke Xue; 2012 Jul; 18(7):595-9. PubMed ID: 22994043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha,25-dihydroxyvitamin D(3) (calcitriol) and its analogue, 19-nor-1alpha,25(OH)(2)D(2), potentiate the effects of ionising radiation on human prostate cancer cells.
    Dunlap N; Schwartz GG; Eads D; Cramer SD; Sherk AB; John V; Koumenis C
    Br J Cancer; 2003 Aug; 89(4):746-53. PubMed ID: 12915889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of RelB by 1,25-dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation.
    Mineva ND; Wang X; Yang S; Ying H; Xiao ZX; Holick MF; Sonenshein GE
    J Cell Physiol; 2009 Sep; 220(3):593-9. PubMed ID: 19373868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN.
    Sun Y; St Clair DK; Fang F; Warren GW; Rangnekar VM; Crooks PA; St Clair WH
    Mol Cancer Ther; 2007 Sep; 6(9):2477-86. PubMed ID: 17876045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of decreased Vitamin D 1alpha-hydroxylase activity in prostate cancer cells.
    Ma JF; Nonn L; Campbell MJ; Hewison M; Feldman D; Peehl DM
    Mol Cell Endocrinol; 2004 Jun; 221(1-2):67-74. PubMed ID: 15223133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aryl hydrocarbon receptor is necessary to protect fetal human pulmonary microvascular endothelial cells against hyperoxic injury: Mechanistic roles of antioxidant enzymes and RelB.
    Zhang S; Patel A; Chu C; Jiang W; Wang L; Welty SE; Moorthy B; Shivanna B
    Toxicol Appl Pharmacol; 2015 Jul; 286(2):92-101. PubMed ID: 25831079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NF-κB subunit RelB regulates the migration and invasion abilities and the radio-sensitivity of prostate cancer cells.
    Wang J; Yi S; Zhou J; Zhang Y; Guo F
    Int J Oncol; 2016 Jul; 49(1):381-92. PubMed ID: 27121503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [NF-κB subunits regulate maspin expression in prostate cancer cells in vitro].
    Ma L; Shen YY; Zhou P; Zhou J; Guo F
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):165-8. PubMed ID: 22780967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha,25-Dihydroxyvitamin D and fish oil synergistically inhibit G1/S-phase transition in prostate cancer cells.
    Istfan NW; Person KS; Holick MF; Chen TC
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):726-30. PubMed ID: 17223546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative signalling by 1,25(OH)2D3 in prostate and breast cancer is suppressed by a mechanism involving histone deacetylation.
    Banwell CM; Singh R; Stewart PM; Uskokovic MR; Campbell MJ
    Recent Results Cancer Res; 2003; 164():83-98. PubMed ID: 12899515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.
    Zhao XY; Peehl DM; Navone NM; Feldman D
    Endocrinology; 2000 Jul; 141(7):2548-56. PubMed ID: 10875257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.